Literature DB >> 27733951

Scopolamine for Management of Extrapyramidal Side Effects as a Result of Antipsychotic Medication Use: A Case Report and Brief Review of the Literature.

Daniel Lampignano1, Taral R Sharma2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27733951      PMCID: PMC5035801          DOI: 10.4088/PCC.15l01874

Source DB:  PubMed          Journal:  Prim Care Companion CNS Disord        ISSN: 2155-7780


× No keyword cloud information.
  7 in total

1.  Selectivity of antimuscarinic compounds for muscarinic receptors of human brain and heart.

Authors:  E W Larson; M A Pfenning; E Richelson
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  A rating scale for extrapyramidal side effects.

Authors:  G M Simpson; J W Angus
Journal:  Acta Psychiatr Scand Suppl       Date:  1970

3.  A controlled clinical trial of the addition of transdermal scopolamine to a standard metoclopramide and dexamethasone antiemetic regimen.

Authors:  B R Meyer; V O'Mara; M M Reidenberg
Journal:  J Clin Oncol       Date:  1987-12       Impact factor: 44.544

4.  Antiemetic-related dystonic reaction unmasked by removal of a scopolamine transdermal patch.

Authors:  Raymond J Roberge
Journal:  J Emerg Med       Date:  2006-04       Impact factor: 1.484

5.  Scopolamine treatment for severe extra-pyramidal signs following organophosphate (chlorpyrifos) ingestion.

Authors:  Iris Kventsel; Matitiahu Berkovitch; Ahuva Reiss; Mordechai Bulkowstein; Eran Kozer
Journal:  Clin Toxicol (Phila)       Date:  2005       Impact factor: 4.467

6.  Scopolamine attenuates haloperidol-induced c-fos expression in the striatum.

Authors:  N Guo; G S Robertson; H C Fibiger
Journal:  Brain Res       Date:  1992-08-14       Impact factor: 3.252

Review 7.  Transdermal hyoscine (Scopolamine). A preliminary review of its pharmacodynamic properties and therapeutic efficacy.

Authors:  S P Clissold; R C Heel
Journal:  Drugs       Date:  1985-03       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.